Roundtable to examine Medicare fraud in wound care

WASHINGTON – Rep. Glenn Grothman, R-Wis., chairman of the Subcommittee on Health Care and Financial Services, has announced a roundtable on “Medicare fraud: Examining the explosive growth in skin substitute spending” will take place July 21 at 2 p.m. ET. Medicare Part B spending on skin substitutes grew from approximately $200 million in 2019 to more than $14.4 billion in 2025. “Skin substitutes are vital medical materials that Americans rely on for wound care, but fraudsters have engaged in kickback schemes to enrich themselves and defraud American taxpayers,” Grothman said. “In just six years, there has been a 7,100% increase in spending on this type of medical care, yet the number of patients receiving these products has only doubled. This gross waste must end. The purpose of this roundtable is to explore the factors that have led to this spending increase and stop waste, fraud, and abuse before it continues further.” During the roundtable, members and participants will discuss common and emerging fraud schemes in the wound care space, especially with dramatically increased spending on skin substitutes for damaged skin. The panel will also discuss the steps the Trump Administration’s Centers for Medicare and Medicaid Services (CMS) has taken to stop fraud occurring within the expected continuous rise in skin substitutes spending by the federal government. The listen participants for the roundtable are:

• Joseph Capper, CEO, MiMedx Group, Inc.
• Dr. Amer Alnajar, chief medical officer and co-founder, Vytalize Health
• Mara McDermott, CEO, Accountable for Health
• Jelena Olmstead, CEO, Levaris Global

Watch a livestream of the roundtable here.